The store will not work correctly when cookies are disabled.
(Z)-3-(6-Fluoro-1H-indol-3-yl)-2-phenylacrylonitrile
ID: ALA1812549
PubChem CID: 53391946
Max Phase: Preclinical
Molecular Formula: C17H11FN2
Molecular Weight: 262.29
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N#C/C(=C\c1c[nH]c2cc(F)ccc12)c1ccccc1
Standard InChI: InChI=1S/C17H11FN2/c18-15-6-7-16-14(11-20-17(16)9-15)8-13(10-19)12-4-2-1-3-5-12/h1-9,11,20H/b13-8+
Standard InChI Key: LGADBOQXTUFTLP-MDWZMJQESA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
1.8527 0.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8516 -0.7107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5664 -1.1235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5646 0.5295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2800 0.1203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2802 -0.7107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0707 -0.9673 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5590 -0.2948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0703 0.3773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3250 1.1620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1319 1.3338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3866 2.1185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1368 -1.1226 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.1926 2.2882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4474 3.0721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8949 3.6860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0844 3.5107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8334 2.7270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6841 0.7209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2357 0.1086 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4 1 1 0
9 10 1 0
5 6 1 0
10 11 2 0
11 12 1 0
2 3 1 0
2 13 1 0
3 6 2 0
12 14 2 0
1 2 2 0
14 15 1 0
5 4 2 0
15 16 2 0
6 7 1 0
16 17 1 0
7 8 1 0
17 18 2 0
18 12 1 0
8 9 2 0
11 19 1 0
9 5 1 0
19 20 3 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 262.29 | Molecular Weight (Monoisotopic): 262.0906 | AlogP: 4.37 | #Rotatable Bonds: 2 |
Polar Surface Area: 39.58 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.27 | CX LogD: 4.27 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.68 | Np Likeness Score: -1.27 |
References
1. Dolusić E, Larrieu P, Moineaux L, Stroobant V, Pilotte L, Colau D, Pochet L, Van den Eynde B, Masereel B, Wouters J, Frédérick R.. (2011) Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators., 54 (15): [PMID:21726069] [10.1021/jm2006782] |